ORIGINAL RESEARCH article

Front. Mol. Biosci., 02 June 2023

Sec. Molecular Diagnostics and Therapeutics

Volume 10 - 2023 | https://doi.org/10.3389/fmolb.2023.1189527

RETRACTED: Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach

Retracted
Geovanny Genaro Reivan OrtizGeovanny Genaro Reivan Ortiz1Carmen Iulia CiongradiCarmen Iulia Ciongradi2M. V. N. L. ChaitanyaM. V. N. L. Chaitanya3Jayasankar NarayananJayasankar Narayanan4Mohamed MohanyMohamed Mohany5Salim S. Al-RejaieSalim S. Al-Rejaie5Jos Luis Arias-GonzlesJosé Luis Arias-Gonzáles6Ioan Srbu
Ioan Sârbu2*Marjan Assefi
Marjan Assefi7*Shaik Vaseem AkramShaik Vaseem Akram8Yusuf DüYusuf Döğüş9Abolfazl Bahrami
Abolfazl Bahrami10*Reza Akhavan-Sigari,Reza Akhavan-Sigari11,12
  • 1Laboratory of Basic Psychology, Behavioral Analysis and Programmatic Development (PAD-LAB), Catholic University of Cuenca, Cuenca, Ecuador
  • 2Department of Surgery-Pediatric Surgery and Orthopedics, “Grigore T. Popa” University of Medicine and Pharmacy, Iași, Romania
  • 3School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India
  • 4Department of Pharmacology, SRM Institute of Science and Technology, SRM College of Pharmacy, Kattankulathu, Tamil Nadu, India
  • 5Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
  • 6Department of Social Sciences, Faculty of Social Studies, University of British Columbia, Vancouver, BC, Canada
  • 7University of North Carolina, Greensboro, NC, United States
  • 8Uttaranchal University, Dehradun, India
  • 9Department of Medical Biochemistry, Faculty of Medicine, Cukurova University, Adana, Türkiye
  • 10Biomedical Center for Systems Biology Science Munich, Ludwig-Maximilians-University, Munich, Germany
  • 11Department of Neurosurgery, University Medical Center Tuebingen, Tuebingen, Germany
  • 12Department of Healthcare Management and Clinical Research, Collegium Humanum Warsaw Management University, Warsaw, Poland

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Reivan Ortiz GG, Ciongradi CI, Chaitanya MVNL, Narayanan J, Mohany M, Al-Rejaie SS, Arias-Gonzáles JL, Sârbu I, Assefi M, Akram SV, Döğüş Y, Bahrami A and Akhavan-Sigari R (2023) Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach. Front. Mol. Biosci. 10:1189527. doi: 10.3389/fmolb.2023.1189527

Received: 19 March 2023; Accepted: 18 May 2023;
Published: 02 June 2023; Retracted: 10 April 2025.

Edited by:

Zhida Liu, Shanxi Academy of Advanced Research and Innovation, China

Reviewed by:

Huiyu Li, University of Texas Southwestern Medical Center, United States
Alexander E. Berezin, Zaporizhia State Medical University, Ukraine

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more